ACB logo

Aurora Cannabis (ACB) Company Overview

Profile

Full Name:

Aurora Cannabis Inc.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

Canada

IPO:

July 15, 2014

Indexes:

Not included

Website:

http://www.auroramj.com

Description:

Aurora Cannabis Inc. is a Canadian company that produces and sells cannabis products for medical and recreational use. They focus on high-quality cultivation, innovative products, and expanding their market presence globally, aiming to meet the growing demand for cannabis in various regions.

Key Details

Price

$5.90

Market Cap

$323.82 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$200.33 M(+52.49% YoY)

Annual EPS

-$1.13(+75.70% YoY)

PE Ratio

655.56

Annual ROE

-12.36%

Annual Debt To Equity

0.10

Beta

1.12

Events Calendar

Earnings

Next earnings date:

Jun 20, 2025

Recent quarterly earnings:

Feb 5, 2025

Recent annual earnings:

Jun 20, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 20, 2024

Analyst ratings

Recent major analysts updates

Dec 18, 20 BMO Capital
Underperform
Nov 25, 20 Stifel Nicolaus
Hold
Nov 25, 20 Stifel
Sell
Nov 25, 20 Seaport Global
Neutral
Nov 25, 20 Piper Sandler
Underweight
Nov 25, 20 Piper Jaffray
Neutral
Nov 25, 20 Needham
Hold
Nov 25, 20 MKM Partners
Sell
Nov 25, 20 Ladenburg Thalmann
Buy
Nov 25, 20 Jefferies
Buy

Screeners with ACB included

Growing Shares Outstanding
Stocks with high beta
Best performing stocks last 3 months
Canadian stocks
Stocks above SMA 50
Healthcare sector
All stocks
Small cap stocks
Specialty & Generic Drug Manufacturers industry
Stocks above SMA 200

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$5.90
ACB price is $5.90

Price All-time High

$1432.68
ACB price is currently -99.59% below its historical high of $1432.68

Price Analysts Target

-
ACB price consensus analysts' forecast is unknown

Price Most Recent Change

+1.36%
ACB price was up +1.36% on Feb 22, 2025

Price YTD Change

+39.81%
ACB price is up +39.81% since January 1st

Price 3-Year Change

-85.71%
ACB price is down -85.71% over the past 3 years

Market cap

Market Cap

$323.82 M
ACB market capitalization is $323.82 million

Market Cap 3-Year Change

-63.49%
ACB market capitalization is down -63.49% over the past 3 years

Market Cap All-time High

$11.23 B
ACB market capitalization is currently -97.12% below its historical high of $11.23 billion

Market Cap Sector Rank

61.38%
ACB market capitalization is higher than 61.38% of companies in Healthcare sector

Technical

Beta

1.12
ACB beta is 1.12

200-day SMA

$5.44
ACB price is currently +8.44% above its 200-day simple moving average

14-day RSI

60.58
ACB 14-day relative strength index is 60.58

30-day Relative Volume

0.60
ACB 30-day relative volume is 0.60

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$200.33 M
ACB annual revenue is $200.33 million

Annual Revenue Analysts Estimate

$343.01 M
ACB annual revenue is currently -41.60% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+52.49%
ACB annual revenue is up +52.49% year-on-year

Annual Revenue Sector Rank

65.29%
ACB annual revenue is higher than 65.29% of companies in Healthcare sector

Profit

Annual Gross Profit

$97.44 M
ACB annual gross profit is $97.44 million

Annual Gross Margin

48.64%
ACB annual gross profit margin is 48.64%

Annual Operating Profit

-$20.07 M
ACB annual operating income is -$20.07 million

Annual Operating Margin

-10.02%
ACB annual operating profit margin is -10.02%

Annual Net Income

-$51.38 M
ACB annual net profit is -$51.38 million

Annual Net Margin

-25.65%
ACB annual net profit margin is -25.65%

EPS

Annual EPS

-$1.13
ACB annual earnings per share is -$1.13

Annual EPS Analysts Estimate

-$0.65
ACB annual earnings per share is currently +73.32% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+75.7%
ACB annual earnings per share is up +75.7% year-on-year

Annual EPS Sector Rank

58.59%
ACB annual earnings per share is higher than 58.59% of companies in Healthcare sector

ROA & ROE

Annual ROA

-7.87%
ACB annual return on assets is -7.87%

Annual ROE

-12.36%
ACB annual return on equity is -12.36%

EBIT & EBITDA

Annual EBIT

-$33.66 M
ACB annual earnings before interest & taxes is -$33.66 million

Annual EBITDA

-$9.15 M
ACB annual EBITDA is -$9.15 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

655.56
ACB price to earnings ratio is 655.56

PE Ratio Sector Rank

98.48%
ACB price to earnings ratio is higher than 98.48% of companies in Healthcare sector

PB Ratio

PB Ratio

0.81
ACB price to book ratio is 0.81

PB Ratio Sector Rank

36.12%
ACB price to book ratio is higher than 36.12% of companies in Healthcare sector

PS Ratio

PS Ratio

1.39
ACB price to sales ratio is 1.39

PS Ratio Sector Rank

31.36%
ACB price to sales ratio is higher than 31.36% of companies in Healthcare sector

Enterprise value

Enterprise Value

$318.43 M
ACB enterprise value is $318.43 million

Enterprise Value Sector Rank

63.02%
ACB enterprise value is higher than 63.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

8.89
ACB EV/EBITDA is 8.89

EV/EBITDA Sector Rank

82.8%
ACB EV/EBITDA is higher than 82.8% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.42
ACB annual current ratio is 3.42

Annual Quick Ratio

1.93
ACB annual quick ratio is 1.93

Leverage

Annual Debt To Equity

0.10
ACB annual debt to equity ratio is 0.10

Annual Interest Coverage Ratio

-3.20
ACB annual interest coverage ratio is -3.20

Risk & Stability

Piotroski F-Score

5
ACB piotroski f-score is 5

Altman Z-Score

-8.95
ACB altman z-score is -8.95

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$620.69 M
ACB annual total assets is $620.69 million

Annual Non Current Assets

$304.96 M
ACB annual long term assets is $304.96 million

Annual Current Assets

$315.72 M
ACB annual total current assets is $315.72 million

Annual Cash & Cash Equivalents

$83.95 M
ACB annual cash & cash equivalents is $83.95 million

Equity

Annual Book Value

$414.28 M
ACB annual book value is $414.28 million

Annual Working Capital

$223.49 M
ACB annual working capital is $223.49 million

Liabilities

Annual Total Liabilities

$175.25 M
ACB annual total liabilities is $175.25 million

Annual Total Long Term Liabilities

$83.02 M
ACB annual total long term liabilities is $83.02 million

Annual Current Liabilities

$92.23 M
ACB annual total current liabilities is $92.23 million

Annual Accounts Payable

$15.04 M
ACB annual accounts payable is $15.04 million

Debt

Annual Total Debt

$77.55 M
ACB annual total debt is $77.55 million

Annual Total Debt 1-Year Change

-53.89%
ACB annual total debt is down -53.89% year-on-year

Annual Long Term Debt

$35.21 M
ACB annual long term debt is $35.21 million

Annual Short Term Debt

$42.35 M
ACB annual short term debt is $42.35 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$220.40 M
ACB annual total expenses is $220.40 million

Annual Operating Expenses

$117.51 M
ACB annual total operating expenses is $117.51 million

Annual Cost Of Goods Sold

$102.89 M
ACB annual cost of goods sold is $102.89 million

Annual SGA

$116.28 M
ACB annual SGA is $116.28 million

Annual D&A

$24.51 M
ACB annual depreciation & amortization is $24.51 million

Annual Interest Expense

$10.51 M
ACB annual interest expense is $10.51 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$50.78 M
ACB annual cash flow from operations is -$50.78 million

Annual CFO 1-Year Change

+42.03%
ACB annual cash flow from operations is up +42.03% year-on-year

Annual CFI

-$4.07 M
ACB annual cash flow from investing activities is -$4.07 million

Annual CFI 1-Year Change

+80.31%
ACB annual cash flow from investing activities is up +80.31% year-on-year

Annual CFF

-$35.52 M
ACB annual cash flow from financing activities is -$35.52 million

Annual CFF 1-Year Change

+16.85%
ACB annual cash flow from financing activities is up +16.85% year-on-year

Free CashFlow

Annual FCF

-$63.35 M
ACB annual free cash flow is -$63.35 million

Annual FCF 1-Year Change

+33.07%
ACB annual free cash flow is up +33.07% year-on-year

CAPEX

Annual CAPEX

$12.57 M
ACB annual capital expenditures is $12.57 million

Annual CAPEX 1-Year Change

+78.14%
ACB annual capital expenditures is up +78.14% year-on-year

Institutional Ownership

Similar stocks

enGene Holdings (ENGN)
TRVI logo
Trevi Therapeutics (TRVI)
HCAT logo
Health Catalyst (HCAT)
GOSS logo
Gossamer Bio (GOSS)
ATAI logo
Atai Life Sciences NV (ATAI)
ANNX logo
Annexon (ANNX)
TRML logo
Tourmaline Bio (TRML)
AHG logo
Akso Health (AHG)
PSNL logo
Personalis (PSNL)

FAQ

  • What is the ticker symbol for Aurora Cannabis?
  • Does Aurora Cannabis pay dividends?
  • What sector is Aurora Cannabis in?
  • What industry is Aurora Cannabis in?
  • What country is Aurora Cannabis based in?
  • When did Aurora Cannabis go public?
  • Is Aurora Cannabis in the S&P 500?
  • Is Aurora Cannabis in the NASDAQ 100?
  • Is Aurora Cannabis in the Dow Jones?
  • When was Aurora Cannabis's last earnings report?
  • When does Aurora Cannabis report earnings?

What is the ticker symbol for Aurora Cannabis?

The ticker symbol for Aurora Cannabis is NASDAQ:ACB

Does Aurora Cannabis pay dividends?

No, Aurora Cannabis does not pay dividends

What sector is Aurora Cannabis in?

Aurora Cannabis is in the Healthcare sector

What industry is Aurora Cannabis in?

Aurora Cannabis is in the Drug Manufacturers - Specialty & Generic industry

What country is Aurora Cannabis based in?

Aurora Cannabis is headquartered in Canada

When did Aurora Cannabis go public?

Aurora Cannabis's initial public offering (IPO) was on July 15, 2014

Is Aurora Cannabis in the S&P 500?

No, Aurora Cannabis is not included in the S&P 500 index

Is Aurora Cannabis in the NASDAQ 100?

No, Aurora Cannabis is not included in the NASDAQ 100 index

Is Aurora Cannabis in the Dow Jones?

No, Aurora Cannabis is not included in the Dow Jones index

When was Aurora Cannabis's last earnings report?

Aurora Cannabis's most recent earnings report was on Feb 5, 2025

When does Aurora Cannabis report earnings?

The next expected earnings date for Aurora Cannabis is Jun 20, 2025